JASON CHOROWSKI: Open Payments
NPI 1649514019 · QUEENS VILLAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 15 payments from 6 companies in 2025. Trend: 2023 $277 · 2024 $333 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $134 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: ARISTADA, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
